| Trial ID: | L3314 |
| Source ID: | NCT04326166
|
| Associated Drug: |
Evogliptin
|
| Title: |
Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Evogliptin|DRUG: Evogliptin|DRUG: Metformin and Evogliptin
|
| Outcome Measures: |
Primary: Change in HbA1c, To assess change from baseline in HbA1c, at 12 weeks | Secondary: Change in HbA1c, To assess change from baseline in HbA1c, at 24 weeks|The percentage of patients with HbA1c <7.0% and <6.5%, To assess the percentage of patients with HbA1c \<7.0% and \<6.5%, at 12 and 24 weeks|Change in FPG, To assess change from baseline in fasting plasma glucose (FPG), at 12 and 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Dong-A ST Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1971
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2020-03-25
|
| Completion Date: |
2021-07-31
|
| Results First Posted: |
|
| Last Update Posted: |
2021-02-17
|
| Locations: |
Sanggye paik pospital, Seoul, Nowon-gu, 01757, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT04326166
|
